Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.016 (European Urology)
We read with interest the article by Necchi et al  regarding the association between bladder multiparametric magnetic resonance imaging (mpMRI) findings after pembrolizumab and the pathological complete response (pCR; pT0). The study sets into the existing extraordinary revolution that is setting the pace of clinical research in bladder tumors. It is a significant article to establish the role of mpMRI to predict the pCR to neoadjuvant immunotherapy.